Are Fenestrated Tracheostomy Tubes Still Valuable?


Journal

American journal of speech-language pathology
ISSN: 1558-9110
Titre abrégé: Am J Speech Lang Pathol
Pays: United States
ID NLM: 9114726

Informations de publication

Date de publication:
09 08 2019
Historique:
pubmed: 19 7 2019
medline: 9 7 2020
entrez: 19 7 2019
Statut: ppublish

Résumé

Purpose The purpose of this clinical focus article is to describe the frequency, indications, and outcomes of fenestrated tracheostomy tube use in a large academic institution. Method A retrospective chart review was conducted to evaluate the use of fenestrated tracheostomy tubes between 2007 and 2017. Patients were included in the study if they were ≥ 18 years of age and received a fenestrated tracheostomy tube in the recent 10-year period. Results Of 2,000 patients who received a tracheostomy, 15 patients had a fenestrated tracheostomy tube; however, only 5 patients received a fenestrated tracheostomy tube at the study institution. The primary reason why the 15 patients received a tracheostomy was chronic respiratory failure (73%); other reasons included airway obstruction (20%) and airway protection (7%). Thirteen (87%) patients received a fenestrated tracheostomy tube for phonation purposes. The remaining 2 patients received it as a step to weaning. Of the 13 patients who received a fenestrated tracheostomy tube for phonation, only 1 patient was not able to phonate. Nine (60%) patients developed some type of complications: granulation only, 2 (13.3%); granulation and tracheomalacia, 2 (13.3%); granulation and stenosis, 4 (26.7%); and granulation, tracheomalacia, and stenosis, 1 (6.7%). Conclusions Fenestrated tracheostomy tubes may assist with phonation in patients who cannot tolerate a 1-way speaking valve; however, the risk of developing granulation tissue, tracheomalacia, and tracheal stenosis exists. Health care providers should be educated on the safe use of a fenestrated tracheostomy tube and other options available to improve phonation while ensuring patient safety.

Identifiants

pubmed: 31318610
doi: 10.1044/2019_AJSLP-18-0187
pmc: PMC6802915
doi:

Types de publication

Evaluation Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1019-1028

Subventions

Organisme : NINR NIH HHS
ID : R01 NR017433
Pays : United States
Organisme : NIA NIH HHS
ID : R42 AG059451
Pays : United States

Références

Anesthesiol Res Pract. 2016;2016:9272865
pubmed: 27073395
Patient. 2018 Apr;11(2):143-145
pubmed: 29071525
Otolaryngol Head Neck Surg. 1984 Dec;92(6):625-7
pubmed: 6440078
Chest. 2004 Mar;125(3):1046-51
pubmed: 15006967
Crit Care Med. 1993 Apr;21(4):512-7
pubmed: 8472569
Crit Care Med. 2004 Nov;32(11):2219-26
pubmed: 15640633
Int J Crit Illn Inj Sci. 2015 Jul-Sep;5(3):179-88
pubmed: 26557488
HNO. 2014 May;62(5):335-41
pubmed: 24718562
J Intensive Care Soc. 2016 Feb;17(1):19-26
pubmed: 28979454
Crit Care. 2002 Dec;6(6):531-5
pubmed: 12493076
J Crit Care. 2016 Jun;33:186-91
pubmed: 26971032
Head Neck. 2013 Apr;35(4):505-10
pubmed: 22522409
Respir Care. 2005 Apr;50(4):538-41
pubmed: 15807918
Intensive Crit Care Nurs. 2018 Jun;46:10-16
pubmed: 29551223
Respir Care. 2014 Jun;59(6):956-71; discussion 971-3
pubmed: 24891201
Laryngoscope. 1997 Jul;107(7):868-71
pubmed: 9217121
Am J Respir Crit Care Med. 2011 Aug 1;184(3):384
pubmed: 21804129
J Commun Disord. 2015 Jul-Aug;56:40-6
pubmed: 26176711
BMJ Case Rep. 2013 Nov 22;2013:null
pubmed: 24272983
Crit Care Med. 2016 Jun;44(6):1075-81
pubmed: 26855430
Patient. 2018 Apr;11(2):175-191
pubmed: 28914429
Respir Care. 2010 Dec;55(12):1661-70
pubmed: 21122174
Chest. 1996 Aug;110(2):494-7
pubmed: 8697856
Paraplegia. 1993 Apr;31(4):203-6
pubmed: 8493034
Am J Surg. 1985 Aug;150(2):279-80
pubmed: 4025713
Ear Nose Throat J. 2006 Jan;85(1):54-5
pubmed: 16509247
J Med Speech Lang Pathol. 2014;21(4):309-318
pubmed: 25429193
Crit Care Med. 2018 Dec;46(12):2010-2017
pubmed: 30096101
Am J Otolaryngol. 1994 Jan-Feb;15(1):63-7
pubmed: 8135331
Laryngoscope. 1990 Oct;100(10 Pt 1):1116-21
pubmed: 2215046

Auteurs

Vinciya Pandian (V)

Johns Hopkins School of Nursing, Baltimore, MD.

Sarah E Boisen (SE)

The Johns Hopkins Hospital, Baltimore, MD.

Shifali Mathews (S)

Johns Hopkins School of Nursing, Baltimore, MD.

Therese Cole (T)

The Johns Hopkins Hospital, Baltimore, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH